U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590284) titled 'Sonazoid CEUS for Early HCC Surveillance' on May 11.
Brief Summary: This study is a multicenter, prospective study. In this study, enrolled subjects are cirrhotic patients of any etiology. The US and Sonazoid CEUS monitoring strategy was performed for cirrhotic patients: US and AFP joint with Sonazoid CEUS every 4 to 6 months, and combined CECT/CEMRI every 12 months.
Study Start Date: May 30
Study Type: INTERVENTIONAL
Condition:
Liver Cirrhosis
Liver Fibrosis
Intervention:
DIAGNOSTIC_TEST: Sonazoid CEUS
Sonazoid CEUS examination
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tianjin Third Central Hospital
Published by HT D...